Suppr超能文献

抗耐药菌药物的研发进展

Development and Research Progress of Anti-Drug Resistant Bacteria Drugs.

作者信息

Cui Xiangyi, Lü Yuhong, Yue Changwu

机构信息

Key Laboratory of Microbial Drugs Innovation and Transformation of Yan'an, School of Basic Medicine, Yan'an University, Yan'an, 716000, Shaanxi, People's Republic of China.

Shaanxi Engineering & Technological Research Center for Conversation & Utilization of Regional Biological Resources, Yan'an University, Yan'an, 716000, Shaanxi, People's Republic of China.

出版信息

Infect Drug Resist. 2021 Dec 21;14:5575-5593. doi: 10.2147/IDR.S338987. eCollection 2021.

Abstract

Bacterial resistance has become increasingly serious because of the widespread use and abuse of antibiotics. In particular, the emergence of multidrug-resistant bacteria has posed a serious threat to human public health and attracted the attention of the World Health Organization (WHO) and the governments of various countries. Therefore, the establishment of measures against bacterial resistance and the discovery of new antibacterial drugs are increasingly urgent to better contain the emergence of bacterial resistance and provide a reference for the development of new antibacterial drugs. In this review, we discuss some antibiotic drugs that have been approved for clinical use and a partial summary of the meaningful research results of anti-drug resistant bacterial drugs in different fields, including the antibiotic drugs approved by the FDA from 2015 to 2020, the potential drugs against drug-resistant bacteria, the new molecules synthesized by chemical modification, combination therapy, drug repurposing, immunotherapy and other therapies.

摘要

由于抗生素的广泛使用和滥用,细菌耐药性问题日益严重。特别是多重耐药菌的出现,对人类公共卫生构成了严重威胁,引起了世界卫生组织(WHO)和各国政府的关注。因此,建立应对细菌耐药性的措施以及发现新型抗菌药物,对于更好地遏制细菌耐药性的出现,并为新型抗菌药物的研发提供参考,变得越来越迫切。在本综述中,我们讨论了一些已获临床批准的抗生素药物,以及不同领域抗耐药菌药物有意义的研究成果的部分总结,包括2015年至2020年美国食品药品监督管理局(FDA)批准的抗生素药物、抗耐药菌的潜在药物、通过化学修饰合成的新分子、联合治疗、药物重新利用、免疫治疗等疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5958/8711564/59af89f618bd/IDR-14-5575-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验